Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 3281968, 19 pages
http://dx.doi.org/10.1155/2016/3281968
Review Article

Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis

1Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China
2Beijing University of Chinese Medicine, Beijing 100029, China
3Department of Oncology, Third Affiliated Hospital of Henan College of Traditional Chinese Medicine, Zhengzhou 450000, China
4Department of Medical Biochemistry and Microbiology, Uppsala University, 75123 Uppsala, Sweden

Received 27 October 2015; Revised 6 February 2016; Accepted 1 March 2016

Academic Editor: Kamal D. Moudgil

Copyright © 2016 Xu Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Hye-Yoon Lee, Jung-Eun Kim, Mikyung Kim, and Joo-Hee Kim, “A review of traditional Korean medical treatment for cancer-related cognitive impairment,” Journal of Korean Medicine, vol. 37, no. 3, pp. 74–86, 2016. View at Publisher · View at Google Scholar
  • Liuting Zeng, and Kailin Yang, “Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach,” Journal of Ethnopharmacology, vol. 199, pp. 68–85, 2017. View at Publisher · View at Google Scholar
  • Bonan Hou, Rui Liu, Zhen Qin, Dan Luo, Qi Wang, and Shuiqing Huang, “Oral Chinese Herbal Medicine as an Adjuvant Treatment for Chemotherapy, or Radiotherapy, Induced Myelosuppression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  • Chen Yan, Hui Meng, Mingwei Yu, Shijian Chen, Yi Zhang, Peiyu Cheng, Xu Sun, Yunfei Ma, Xiaomin Wang, Jin-Ping Li, Ganlin Zhang, Jiayun Nian, Guowang Yang, and Lin Yang, “Elevated heparanase expression is associated with poor prognosis in breast cancer: A study based on systematic review and TCGA data,” Oncotarget, vol. 8, no. 26, pp. 43521–43535, 2017. View at Publisher · View at Google Scholar
  • Zhixue Wang, Fanghua Qi, Yangang Cui, Lin Zhao, Xiaogang Sun, Wei Tang, and Pingping Cai, “An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics,” BioScience Trends, vol. 12, no. 3, pp. 220–239, 2018. View at Publisher · View at Google Scholar
  • Dan Mao, Lei Feng, and Hui Gong, “The Antitumor and Immunomodulatory Effect of Yanghe Decoction in Breast Cancer Is Related to the Modulation of the JAK/STAT Signaling Pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2018, pp. 1–9, 2018. View at Publisher · View at Google Scholar
  • Dan Mao, Lei Feng, Siqi Huang, Shaofan Zhang, Weijun Peng, and Sifang Zhang, “Meta-Analysis of Xihuang Pill Efficacy When Combined with Chemotherapy for Treatment of Breast Cancer,” Evidence-Based Complementary and Alternative Medicine, vol. 2019, pp. 1–14, 2019. View at Publisher · View at Google Scholar